57 related articles for article (PubMed ID: 37436606)
1. Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database.
Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-Pruszyński K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience.
Chin RI; Schiff JP; Bommireddy A; Kang KH; Andruska N; Price AT; Green OL; Huang Y; Korenblat K; Parikh PJ; Olsen J; Samson PP; Henke LE; Kim H; Badiyan SN
Clin Transl Radiat Oncol; 2023 Jul; 41():100627. PubMed ID: 37441543
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
Hu Z; Yang Z; Pan Y; Fu Y; Wang J; Zhou Z; Chen M; Hu D; Zhang Y
Front Pharmacol; 2023; 14():1210835. PubMed ID: 37456741
[No Abstract] [Full Text] [Related]
4. Research trends in cholangiocarcinoma treatments during the last 3 decades.
Lin K; Cao J; Chen H; Topatana W; Cai J; Zhang B; Hu J; Jin R
Heliyon; 2023 Jul; 9(7):e17100. PubMed ID: 37455974
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
Kobayashi S; Ikeda M; Nakachi K; Ueno M; Okusaka T; Todaka A; Satoi S; Tomokuni A; Konishi M; Furuse J
Ann Surg Oncol; 2023 Nov; 30(12):7331-7337. PubMed ID: 37450093
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous transhepatic cholangial drainage or antibiotic therapy worsens response to immunotherapy in advanced cholangiocarcinoma.
Huang Q; Wang F; Zhang X; Liu J; Dou X; Feng R; Zhu K; Jiang S; Zhang Y; Yue J
BMC Cancer; 2023 Jul; 23(1):657. PubMed ID: 37442960
[TBL] [Abstract][Full Text] [Related]
7. Inverse probability of treatment weighting analysis of laparoscopic versus open Sg4b-5 bi-segmentectomy in patients with gallbladder cancer.
Fontana AP; Russolillo N; Di Menno Stavron J; Langella S; Tesoriere RL; Ricotti A; Ferrero A
Updates Surg; 2023 Sep; 75(6):1471-1480. PubMed ID: 37495871
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches.
Miller KN; Thomas SM; Record SM; Rosenberger LH; DiNome ML; DiLalla G; Force JM; Hwang ES; Plichta JK
Ann Surg Oncol; 2023 Oct; 30(10):6141-6150. PubMed ID: 37466869
[TBL] [Abstract][Full Text] [Related]
9. The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma.
Ratti F; Marino R; Catena M; Pascale MM; Buonanno S; De Cobelli F; Aldrighetti L
Updates Surg; 2023 Oct; 75(7):1919-1939. PubMed ID: 37452927
[TBL] [Abstract][Full Text] [Related]
10. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.
Ong KH; Hsieh YY; Sun DP; Huang SK; Tian YF; Chou CL; Shiue YL; Joseph K; Chang IW
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443694
[TBL] [Abstract][Full Text] [Related]
11. ASO Author Reflections: Liver-Directed Therapies for Intrahepatic Cholangiocarcinoma: Are We Comparing Apples and Oranges?
Masoud SJ; Rhodin KE; Eckhoff AM; Lidsky ME
Ann Surg Oncol; 2023 Oct; 30(11):6647-6648. PubMed ID: 37543556
[No Abstract] [Full Text] [Related]
12. Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma.
Masoud SJ; Rhodin KE; Kanu E; Bao J; Eckhoff AM; Bartholomew AJ; Howell TC; Aykut B; Kosovec JE; Palta M; Befera NT; Kim CY; Herbert G; Shah KN; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Oct; 30(11):6639-6646. PubMed ID: 37436606
[TBL] [Abstract][Full Text] [Related]
13. Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablation.
Kanu EN; Rhodin KE; Masoud SJ; Eckhoff AM; Bartholomew AJ; Howell TC; Bao J; Befera NT; Kim CY; Blazer DG; Zani S; Nussbaum DP; Allen PJ; Lidsky ME
J Surg Oncol; 2023 Dec; 128(8):1329-1339. PubMed ID: 37671594
[TBL] [Abstract][Full Text] [Related]
14. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
15. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
16. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
